These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34641875)

  • 1. An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs.
    Permanasari AA; Aoki-Utsubo C; Wahyuni TS; Tumewu L; Adianti M; Widyawaruyanti A; Hotta H; Hafid AF
    BMC Complement Med Ther; 2021 Oct; 21(1):260. PubMed ID: 34641875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Hepatitis C Virus Activity of a Crude Extract from Longan (Dimocarpus longan Lour.) Leaves.
    Apriyanto DR; Aoki C; Hartati S; Hanafi M; Kardono LB; Arsianti A; Louisa M; Sudiro TM; Dewi BE; Sudarmono P; Soebandrio A; Hotta H
    Jpn J Infect Dis; 2016 May; 69(3):213-20. PubMed ID: 26255732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
    Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
    J Virol; 2019 May; 93(10):. PubMed ID: 30842319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anti-hepatitis C virus activity of Ruta angustifolia extract with NS3 protein inhibitor.
    Wahyuni TS; Mahfud H; Permatasari AA; Widyawaruyanti A; Fuad A
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells.
    Rehman S; Ashfaq UA; Ijaz B; Riazuddin S
    Microb Pathog; 2018 Aug; 121():198-209. PubMed ID: 29775725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.
    Zoulim F; Moreno C; Lee SS; Buggisch P; Horban A; Lawitz E; Corbett C; Lenz O; Fevery B; Verbinnen T; Shukla U; Jessner W
    Virol J; 2018 Jan; 15(1):26. PubMed ID: 29378602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.
    Wahyuni TS; Tumewu L; Permanasari AA; Apriani E; Adianti M; Rahman A; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Nasronudin ; Fuchino H; Kawahara N; Shoji I; Deng L; Aoki C; Hotta H
    Virol J; 2013 Aug; 10():259. PubMed ID: 24089993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin.
    Kanda T; Nakamoto S; Sasaki R; Nakamura M; Yasui S; Haga Y; Ogasawara S; Tawada A; Arai M; Mikami S; Imazeki F; Yokosuka O
    Int J Med Sci; 2016; 13(4):310-5. PubMed ID: 27076789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an Oligostilbene, Vaticanol B, from Dryobalanops aromatica Leaves as an Antiviral Compound against the Hepatitis C Virus.
    Aoki-Utsubo C; Hanafi M; Armanti DT; Fuchino H; Kawahara N; Hartati S; Widyawaruyanti A; Sudarmono P; Kameoka M; Hotta H
    Biol Pharm Bull; 2023; 46(8):1079-1087. PubMed ID: 37532559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkaloid and benzopyran compounds of Melicope latifolia fruit exhibit anti-hepatitis C virus activities.
    Widyawaruyanti A; Tanjung M; Permanasari AA; Saputri R; Tumewu L; Adianti M; Aoki-Utsubo C; Hotta H; Hafid AF; Wahyuni TS
    BMC Complement Med Ther; 2021 Jan; 21(1):27. PubMed ID: 33435968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
    Manns M; Marcellin P; Poordad F; de Araujo ES; Buti M; Horsmans Y; Janczewska E; Villamil F; Scott J; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):414-26. PubMed ID: 24907224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent virucidal activity of honeybee "Apis mellifera" venom against Hepatitis C Virus.
    Sarhan M; El-Bitar AMH; Hotta H
    Toxicon; 2020 Dec; 188():55-64. PubMed ID: 33068557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.
    Jacobson IM; Dore GJ; Foster GR; Fried MW; Radu M; Rafalsky VV; Moroz L; Craxi A; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; De La Rosa G; Kalmeijer R; Scott J; Sinha R; Beumont-Mauviel M
    Lancet; 2014 Aug; 384(9941):403-13. PubMed ID: 24907225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.
    Foster GR; Hézode C; Bronowicki JP; Carosi G; Weiland O; Verlinden L; van Heeswijk R; van Baelen B; Picchio G; Beumont M
    Gastroenterology; 2011 Sep; 141(3):881-889.e1. PubMed ID: 21699786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus.
    Ratnoglik SL; Aoki C; Sudarmono P; Komoto M; Deng L; Shoji I; Fuchino H; Kawahara N; Hotta H
    Microbiol Immunol; 2014 Mar; 58(3):188-94. PubMed ID: 24438164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
    Pol S; Corouge M; Mallet V; Sogni P
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
    Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
    Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action.
    Paeshuyse J; Dallmeier K; Neyts J
    Curr Opin Virol; 2011 Dec; 1(6):590-8. PubMed ID: 22440916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline resistance associated substitutions in HCV genotype 1 infected cohort treated with Simeprevir, Daclatasvir and Sofosbuvir in Brazil.
    Aguiar BF; Campos GRF; Rodrigues JPV; Marques NN; Molina BF; Bittar C; Souza FF; Martinelli ALC; Rahal P; Pereira LRL
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):329-339. PubMed ID: 31523019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.